Paper39837814
Targeting SRSF1 improves cancer immunotherapy by dually acting on CD8+T and tumor cells.
Zhu GQ and 20 others. Signal Transduct Target Ther, 2025. Cited by 17 papers, by iCite.
Cite this record
ConductScience Library. Targeting SRSF1 improves cancer immunotherapy by dually acting on CD8+T and tumor cells. Papers, record 39837814. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39837814
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Serine-Arginine Splicing Factors | Major topic |
| CD8-Positive T-Lymphocytes | Major topic |
| Neoplasms | Major topic |
| Immunotherapy | Major topic |
| Animals | |
| Mice | |
| Humans | |
| Cell Line, Tumor | |
| Tumor Microenvironment |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 82073217 | National Natural Science Foundation of China (National Science Foundation of China) | PubMed |
Source PubMed
References38
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29414259 | CD8 T Cell Exhaustion in Chronic Infection and Cancer: Opportunities for Interventions. | Annu Rev Med | 2018 | https://conductscience.org/library/papers/29414259 | PubMed |
| 2 | 33910046 | Tumors exploit FTO-mediated regulation of glycolytic metabolism to evade immune surveillance. | Cell Metab | 2021 | https://conductscience.org/library/papers/33910046 | PubMed |
| 3 | 22245967 | The splicing factor SRSF1 regulates apoptosis and proliferation to promote mammary epithelial cell transformation. | Nat Struct Mol Biol | 2012 | https://conductscience.org/library/papers/22245967 | PubMed |
| 4 | 31200124 | The RNA-binding protein SRSF1 is a key cell cycle regulator via stabilizing NEAT1 in glioma. | Int J Biochem Cell Biol | 2019 | https://conductscience.org/library/papers/31200124 | PubMed |
| 5 | 31186238 | β-Catenin Activation Promotes Immune Escape and Resistance to Anti-PD-1 Therapy in Hepatocellular Carcinoma. | Cancer Discov | 2019 | https://conductscience.org/library/papers/31186238 | PubMed |
| 6 | 8921970 | Major histocompatibility complex class I presentation of ovalbumin peptide 257-264 from exogenous sources: protein context influences the degree of TAP-independent presentation. | Eur J Immunol | 1996 | https://conductscience.org/library/papers/8921970 | PubMed |
| 7 | 26431027 | SRSF1-Regulated Alternative Splicing in Breast Cancer. | Mol Cell | 2015 | https://conductscience.org/library/papers/26431027 | PubMed |
| 8 | 33398183 | Mitochondrial stress induced by continuous stimulation under hypoxia rapidly drives T cell exhaustion. | Nat Immunol | 2021 | https://conductscience.org/library/papers/33398183 | PubMed |
| 9 | 35537409 | IL-6 blockade in cancer patients treated with immune checkpoint blockade: A win-win strategy. | Cancer Cell | 2022 | https://conductscience.org/library/papers/35537409 | PubMed |
| 10 | 30778251 | The transcription factor c-Myb regulates CD8+ T cell stemness and antitumor immunity. | Nat Immunol | 2019 | https://conductscience.org/library/papers/30778251 | PubMed |
| 11 | 28367982 | Okanin, effective constituent of the flower tea Coreopsis tinctoria, attenuates LPS-induced microglial activation through inhibition of the TLR4/NF-κB signaling pathways. | Sci Rep | 2017 | https://conductscience.org/library/papers/28367982 | PubMed |
| 12 | 20118245 | Alternative splicing factor/splicing factor 2 regulates the expression of the zeta subunit of the human T cell receptor-associated CD3 complex. | J Biol Chem | 2010 | https://conductscience.org/library/papers/20118245 | PubMed |
| 13 | 24368769 | Ubiquitination regulates expression of the serine/arginine-rich splicing factor 1 (SRSF1) in normal and systemic lupus erythematosus (SLE) T cells. | J Biol Chem | 2014 | https://conductscience.org/library/papers/24368769 | PubMed |
| 14 | 33951476 | A kinome screen reveals that Nemo-like kinase is a key suppressor of hepatic gluconeogenesis. | Cell Metab | 2021 | https://conductscience.org/library/papers/33951476 | PubMed |
| 15 | 33664238 | SRSF1 inhibits autophagy through regulating Bcl-x splicing and interacting with PIK3C3 in lung cancer. | Signal Transduct Target Ther | 2021 | https://conductscience.org/library/papers/33664238 | PubMed |
| 16 | 33850328 | Advances in immunotherapy for hepatocellular carcinoma. | Nat Rev Gastroenterol Hepatol | 2021 | https://conductscience.org/library/papers/33850328 | PubMed |
| 17 | 35537411 | Boosting anticancer immunotherapy through androgen receptor blockade. | Cancer Cell | 2022 | https://conductscience.org/library/papers/35537411 | PubMed |
| 18 | 9778245 | Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. | Cell | 1998 | https://conductscience.org/library/papers/9778245 | PubMed |
| 19 | 35584166 | Nivolumab in Esophageal Squamous-Cell Carcinoma. | N Engl J Med | 2022 | https://conductscience.org/library/papers/35584166 | PubMed |
| 20 | 26321679 | Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression. | Cell | 2015 | https://conductscience.org/library/papers/26321679 | PubMed |
Cited by14
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42640343 | Integrated genome-wide high-throughput screening and functional validation identifies Sm proteins as essential splicing regulators for gastric cancer progression. | Funct Integr Genomics | 2026 | https://conductscience.org/library/papers/42640343 | PubMed |
| 42625101 | RNA splicing in health and disease. | Mol Biomed | 2026 | https://conductscience.org/library/papers/42625101 | PubMed |
| 42266677 | Enhancing targeted strategies for cancer immunotherapy by elucidating mRNA processing mechanisms. | Front Immunol | 2026 | https://conductscience.org/library/papers/42266677 | PubMed |
| 42063703 | Electrospun nanofibers for gastric cancer: local therapeutics, biomimetic models, and diagnostic interfaces. | Front Oncol | 2026 | https://conductscience.org/library/papers/42063703 | PubMed |
| 41992956 | SRSF1 as a promising biomarker and key player in the pathogenesis of Alzheimer's disease. | Mol Med Rep | 2026 | https://conductscience.org/library/papers/41992956 | PubMed |
| 41663524 | Peripheral blood CD14 + monocytes in luminal breast carcinoma subtypes: in preliminary research and overview of candidate biomarker proteins. | Sci Rep | 2026 | https://conductscience.org/library/papers/41663524 | PubMed |
| 41596632 | Immunotherapy in Head and Neck Cancer-Where Are We Now and Where Are We Headed? | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41596632 | PubMed |
| 41335261 | Immunotherapy in multiple myeloma: advances from immune microenvironment insights to clinical application. | Mol Biol Rep | 2025 | https://conductscience.org/library/papers/41335261 | PubMed |
| 40732992 | Orchestrating Nutrient Homeostasis: RNA-Binding Proteins as Molecular Conductors in Metabolic Disease Pathogenesis. | Nutrients | 2025 | https://conductscience.org/library/papers/40732992 | PubMed |
| 40537877 | Mechanism of LINC00958 in ferroptosis of breast cancer through the SRSF1/GPX4 axis. | Hereditas | 2025 | https://conductscience.org/library/papers/40537877 | PubMed |
| 40420185 | Research progress of CD73-adenosine signaling regulating hepatocellular carcinoma through tumor microenvironment. | J Exp Clin Cancer Res | 2025 | https://conductscience.org/library/papers/40420185 | PubMed |
| 40315321 | Targeting HMGB2 acts as dual immunomodulator by bolstering CD8+ T cell function and inhibiting tumor growth in hepatocellular carcinoma. | Sci Adv | 2025 | https://conductscience.org/library/papers/40315321 | PubMed |
| 40308513 | Transcatheter arterial chemoembolization for lung malignant tumors. | Front Oncol | 2025 | https://conductscience.org/library/papers/40308513 | PubMed |
| 40232354 | Bispecific antibody targeting CD155 mediates T-cell immunotherapy against human gynecological malignancies. | Invest New Drugs | 2025 | https://conductscience.org/library/papers/40232354 | PubMed |
Data1
The data bank entries PubMed's record names. Trial numbers are under Trials.
| Data bank | Accession |
|---|---|
| GEO | GSE202642 |
Source GEO
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39837814
GET https://conductscience.org/api/papers/v1/39837814/authors?page=2